SNX19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.620820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.691400E-01
Normal-vs-Stage2
1.496640E-01
Normal-vs-Stage3
4.484100E-02
Normal-vs-Stage4
4.258600E-01
Stage1-vs-Stage2
3.987800E-01
Stage1-vs-Stage3
3.729600E-02
Stage1-vs-Stage4
8.630800E-01
Stage2-vs-Stage3
1.291960E-01
Stage2-vs-Stage4
6.047000E-01
Stage3-vs-Stage4
1.243760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.581620E-01
Normal-vs-AfricanAmerican
6.189400E-01
Normal-vs-Asian
1.928180E-01
Caucasian-vs-AfricanAmerican
2.221400E-01
Caucasian-vs-Asian
4.810800E-01
AfricanAmerican-vs-Asian
2.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.377400E-01
Normal-vs-Female
2.134600E-01
Male-vs-Female
5.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.318980E-01
Normal-vs-Age(41-60Yrs)
2.575400E-01
Normal-vs-Age(61-80Yrs)
1.520750E-01
Normal-vs-Age(81-100Yrs)
9.179900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.641400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.963800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.882000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.062000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.565170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.130390E-01
Normal-vs-Daily Drinker
7.962400E-02
Normal-vs-Weekly Drinker
1.734350E-01
Normal-vs-Occasional Drinker
1.970210E-01
Normal-vs-Social Drinker
2.531000E-01
Non Drinker-vs-Daily Drinker
8.125800E-01
Non Drinker-vs-Weekly Drinker
8.773800E-01
Non Drinker-vs-Occasional Drinker
5.814200E-01
Non Drinker-vs-Social Drinker
2.550000E-01
Daily Drinker-vs-Weekly Drinker
7.289200E-01
Daily Drinker-vs-Occasional Drinker
4.522200E-01
Daily Drinker-vs-Social Drinker
1.768160E-01
Weekly Drinker-vs-Occasional Drinker
7.530200E-01
Weekly Drinker-vs-Social Drinker
4.042600E-01
Occasional Drinker-vs-Social Drinker
5.767000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.632400E-02
Normal-vs-Grade 2
1.815210E-03
Normal-vs-Grade 3
3.618700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.434200E-01
Grade 1-vs-Grade 3
6.647800E-02
Grade 1-vs-Grade 4
4.632400E-02
Grade 2-vs-Grade 3
2.505000E-01
Grade 2-vs-Grade 4
1.815210E-03
Grade 3-vs-Grade 4
3.618700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.218100E-02
Normal-vs-NonDiabetic
1.207440E-01
Diabetic-vs-NonDiabetic
1.658170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.452800E-01
Normal-vs-NoPancreatitis
9.503600E-02
Pancreatitis-vs-NoPancreatitis
1.583990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.826600E-01
Normal-vs-N1
1.669050E-01
N0-vs-N1
6.440400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.662800E-01
Normal-vs-TP53-NonMutant
2.208200E-01
TP53-Mutant-vs-TP53-NonMutant
3.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
